Published on 17 Oct 2024 on GuruFocus.com · via Yahoo Finance
State Street Corp's Strategic Reduction in Editas Medicine Inc Holdings
Overview of Recent Transaction by State Street Corp
On September 30, 2024, State Street Corp executed a significant transaction involving the sale of 2,128,891 shares of Editas Medicine Inc (NASDAQ:EDIT), a pioneering firm in the biotechnology sector. This move reduced their holding to 2,462,022 shares, reflecting a notable shift in their investment strategy regarding EDIT. The shares were traded at a price of $3.41, marking a pivotal adjustment in State Street Corp's portfolio.
Profile of State Street Corp